Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Cash from Financing Activities
Meridian Bioscience Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Cash from Financing Activities
-$34.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Financing Activities
$116m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Financing Activities
-$338m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-4%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Financing Activities
-$598.3m
|
CAGR 3-Years
-129%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-34%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Financing Activities
-$21.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
See Also
What is Meridian Bioscience Inc's Cash from Financing Activities?
Cash from Financing Activities
-34.3m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Cash from Financing Activities amounts to -34.3m USD.
What is Meridian Bioscience Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-4%
Over the last year, the Cash from Financing Activities growth was -10%.